GB0008029D0 - New vaccine formulations - Google Patents

New vaccine formulations

Info

Publication number
GB0008029D0
GB0008029D0 GB0008029A GB0008029A GB0008029D0 GB 0008029 D0 GB0008029 D0 GB 0008029D0 GB 0008029 A GB0008029 A GB 0008029A GB 0008029 A GB0008029 A GB 0008029A GB 0008029 D0 GB0008029 D0 GB 0008029D0
Authority
GB
United Kingdom
Prior art keywords
vaccine formulations
new vaccine
new
formulations
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0008029A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Onyvax Ltd
Original Assignee
Onyvax Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Onyvax Ltd filed Critical Onyvax Ltd
Priority to GB0008029A priority Critical patent/GB0008029D0/en
Priority to EP00931400A priority patent/EP1178822B1/en
Priority to KR1020017014806A priority patent/KR20020027318A/en
Priority to PCT/GB2000/001918 priority patent/WO2000071155A2/en
Priority to AT00931400T priority patent/ATE259655T1/en
Priority to AU49356/00A priority patent/AU4935600A/en
Priority to DE60008368T priority patent/DE60008368T2/en
Priority to AU49357/00A priority patent/AU4935700A/en
Priority to CA002374294A priority patent/CA2374294A1/en
Priority to PCT/GB2000/001921 priority patent/WO2000071156A2/en
Priority to ES00931400T priority patent/ES2215662T3/en
Priority to JP2000619457A priority patent/JP2003500366A/en
Publication of GB0008029D0 publication Critical patent/GB0008029D0/en
Ceased legal-status Critical Current

Links

GB0008029A 1999-05-21 2000-04-01 New vaccine formulations Ceased GB0008029D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GB0008029A GB0008029D0 (en) 2000-04-01 2000-04-01 New vaccine formulations
EP00931400A EP1178822B1 (en) 1999-05-21 2000-05-19 Whole cell cancer vaccine comprising co-cultured malignant and non-malignant cells
KR1020017014806A KR20020027318A (en) 1999-05-21 2000-05-19 New vaccine formulations-2
PCT/GB2000/001918 WO2000071155A2 (en) 1999-05-21 2000-05-19 New vaccine formulations - 2
AT00931400T ATE259655T1 (en) 1999-05-21 2000-05-19 WHOLE CELL CANCER VACCINE CONTAINING CO-CULTURED MALIGINAL AND NON-MALIGINAL CELLS
AU49356/00A AU4935600A (en) 1999-05-21 2000-05-19 New vaccine formulations - 2
DE60008368T DE60008368T2 (en) 1999-05-21 2000-05-19 WHOLE CELLS OF CANCER VACCINE, CONTAINING CO-CULTIVATED MALIGNE AND NON-MALIGNE CELLS
AU49357/00A AU4935700A (en) 1999-05-21 2000-05-19 New vaccine formulations-3
CA002374294A CA2374294A1 (en) 1999-05-21 2000-05-19 New vaccine formulations - 2
PCT/GB2000/001921 WO2000071156A2 (en) 1999-05-21 2000-05-19 New vaccine formulations-3
ES00931400T ES2215662T3 (en) 1999-05-21 2000-05-19 VACCINE OF WHOLE CELLS FOR CANCER CONTAINING MALIGNAL AND NON-MALIGNED CELL CELLS.
JP2000619457A JP2003500366A (en) 1999-05-21 2000-05-19 New vaccine preparation 2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0008029A GB0008029D0 (en) 2000-04-01 2000-04-01 New vaccine formulations

Publications (1)

Publication Number Publication Date
GB0008029D0 true GB0008029D0 (en) 2000-05-24

Family

ID=9888993

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0008029A Ceased GB0008029D0 (en) 1999-05-21 2000-04-01 New vaccine formulations

Country Status (1)

Country Link
GB (1) GB0008029D0 (en)

Similar Documents

Publication Publication Date Title
GB0020953D0 (en) Vaccine
HUP0301043A3 (en) Vaccine
IL155072A0 (en) Vaccine
HUP0301413A3 (en) Vaccine compositions
HUP0302117A3 (en) Vaccine composition
GB0020089D0 (en) Vaccine Composition
AU4433702A (en) Vaccines
GB0009583D0 (en) Respiratory formulations
AU1591402A (en) Vaccine
GB0024200D0 (en) Component vaccine
GB0015490D0 (en) Novel formulations
GB0014288D0 (en) Vaccine
GB0009612D0 (en) Therapeutic formulations
GB0026334D0 (en) Vaccine
GB0014845D0 (en) Vaccine
HUP0600589A2 (en) Adjuvant combination formulations
GB0025694D0 (en) Vaccine
GB0003082D0 (en) Vaccine
GB9911823D0 (en) New vaccine formulations
GB0015722D0 (en) Vaccine
GB0006693D0 (en) Vaccine
GB0004533D0 (en) Vaccines
GB0008029D0 (en) New vaccine formulations
GB0015935D0 (en) Vaccine
GB0006770D0 (en) Vaccine composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)